Relationship between Rgs2 gene expression level and anxiety and depression-like behaviour in a mutant mouse model: Serotonergic involvement

International Journal of Neuropsychopharmacology

Volumn 15, Issue 9, 2012, Pages 1307-1318

  Lifschytz, Tzuri ^a   Broner, Esther Channah ^a   Zozulinsky, Polina ^a   Slonimsky, Alexandra ^a   Eitan, Renana ^a   Greenbaum, Lior ^a   Lerer, Bernard ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Anxiety; behavioural tests; brain gene expression levels; depression; RGS2 gene; sociability

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; RGS2 PROTEIN; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BASAL BODY TEMPERATURE; BRAIN CORTEX; CONTROLLED STUDY; DEPRESSION; GENE EXPRESSION; GENE MUTATION; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HYPOTHALAMUS; INDUCED HYPOTHERMIA; MALE; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAPHE NUCLEUS; SEROTONINERGIC SYSTEM;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANALYSIS OF VARIANCE; ANIMALS; ANXIETY; BRAIN CHEMISTRY; DEPRESSION; FEEDING BEHAVIOR; FEMALE; GENE EXPRESSION; GENOTYPE; MALE; MICE; MICE, INBRED C57BL; MUTATION; REAL-TIME POLYMERASE CHAIN REACTION; RGS PROTEINS; SEROTONIN; SEROTONIN RECEPTOR AGONISTS; SOCIAL BEHAVIOR; SOCIAL ENVIRONMENT; SWIMMING;

EID: 84871483557     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145711001453     Document Type: Article

References (52)

1. Amstadter AB, Koenen KC, Ruggiero KJ, Acinero R, et al. (2009). Variant in RGS2 moderates posttraumatic stress symptoms following potentially traumatic event exposure. Journal of Anxiety Disorders 23, 369-373.
2. Amstadter AB, Koenen KC, Ruggiero KJ, Galea S, et al. (2009). Variation in RGS2 is associated with suicidal ideation in an epidemiological study of adults exposed to the 2004 Florida hurricanes. Archives of Suicide Research 13, 349-354.
3. Bell CJ, Nutt DJ (1998). Serotonin and panic. British Journal of Psychiatry 172, 465-471.
4. Bernstein LS, Ramineni S, Hague C, Cladman W, et al. (2004). RGS2 binds directly and selectively to the M1 muscarinic acetylcholine receptor third intracellular loop to modulate Gq/11alpha signaling. Journal of Biological Chemistry 279, 21248-21256.
5. Bevins RA, Besheer J (2006). Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study 'recognition memory'. Nature Protocols 1, 1306-1311.
6. Chakir K, Depry C, Dimaano VL, Zhu WZ, et al. (2011). RGS2 is a primary terminator of b2-adrenergic receptor-mediated G(i) signaling. Journal of Molecular and Cellular Cardiology 50, 1000-1007.
7. Crawley JN (2007). Mouse behavioral assays relevant to the symptoms of autism. Brain Pathology 17, 448-459.
8. Cryan JF, Dalvi A, Jin SH, Hirsch BR, et al. (2001). Use of dopamine beta hydroxylase deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs. Journal of Pharmacology and Experimental Therapeutics 298, 651-657.
9. Cui H, Nishi Guchi N, Yanagi M, Fututake M, et al. (2008). Association of RGS2 gene polymorphisms with suicide and increased RGS2 immunoreactivity in the postmortem brain of suicide victims. Neuropsychopharmacology 33, 1537-1544.
10. David DJ, Klemenhagen KC, Holick KA, Saxe MD, et al. (2007). Efficacy of the MCHR1 antagonist n-[3-(1-{[4-(3,4-difluorophenoxy)phenyl]methyl}(4- piperidyl))-4-mrthylphenyl]-2-methylpropanamide(SNAP 94847) in mouse models of anxiety and depression following acute and chronic administration is independent of hippocampal neurogenesis. Journal of Pharmacology and Experimental Therapeutics 321, 237-248.
11. Garcia-Gutierrez MS, Perez-Ortiz JM, Gutierrez-Adan A, Manzanares J (2010). Depression-resistant endophenotype in mice overexpressing cannabinoid CB(2) receptors. British Journal of Pharmacology 160, 1773-1784.
12. Greenbaum L, Smith RC, Rigbi A, Strous R, et al. (2009). Further evidence for association of the RGS2 gene with antipsychotic-induced Parkinsonism: protective role of a functional polymorphism in the 3k-untranslated region. Pharmacogenomics Journal 9, 103-110.
13. Greenbaum L, Strous RD, Kanyas K, Merbl Y, et al. (2007). Association of the RGS2 gene with extrapyramidal symptoms induced by treatment with antipsychotic medication. Pharmacogenetics and Genomics 17, 519-528.
14. Hague C, Bernstein LS, Ramineni S, Minneman KP, Hepler JR (2005). Selective inhibition of alpha1Aadrenergic receptor signaling by RGS2 association with the receptor third intracellular loop. Journal of Biological Chemistry 280, 27289-27295.
15. Han J, Mark MD, Li X, Xie M, et al. (2006). RGS2 determines short-term synaptic plasticity in hippocampla neurons by regulating gi/o-mediated inhibition of Ca2+ channels. Neuron 51, 575-586.
16. Heximer SP, Kunsten RH, Sun X, Kaltenbronn KM, et al. (2003). Hypertension and prolong vasoconstrictor signaling in RGS2-deficient mice. Journal of Clinical Investigation 111, 445-452.
17. Hollinger S, Hepler JR (2002). Cellular regulation of RGS proteins : modulators and integrators of G protein signaling. Pharmacological Reviews 54, 527-559.
18. Ingi T, Aoki Y (2002). Expression of RGS2, RGS4 and RGS7 in the developing postnatal brain. European Journal of Neuroscience 15, 929-936.
19. Ingi T, Krumins AM, Chidiac P, Brothers GM, et al. (1998). Dynamic regulation of RGS2 suggests a novel mechanism in G-protein signaling and neuronal plasticity. Journal of Neuroscience 18, 7178-7188.
20. Koenen KC, Amstadter AB, Ruggiero KJ, Acinero R, et al. (2009). RGS2 and generalized anxiety disorder in an epidemiologic sample of hurricane-exposed adults. Depression and Anxiety 26, 309-315.
21. Kozisek ME, Middleman D, Bylund DB (2008). Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase b in the mechanism of action of antidepressant therapies. Pharmacology and Therapeutics 117, 30-51.
22. Kreiss DS, Lucki I (1995). Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. Journal of Pharmacology and Experimental Therapeutics 274, 866-876.
23. Labouebe G, Lomazzi M, Cruz HG, Creton C, et al. (2008). RGS2 modulates coupling between GABAB receptors and GIRK channels in dopamine neurons of the ventral tegmental area. Nature Neuroscience 10, 1559-1568.
24. Leygraf A, Hohoff C, Freitag C, Willis-Owen SA, et al. (2006). RGS2 gene polymorphisms as modulators of anxiety in humans? Journal of Neural Transmission 113, 1921-1925.
25. Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta delta c(T)) method. Methods 25, 402-408.
26. Lomazzi M, Slesinger PA, Luscher C (2008). Addictive drugs modulate GIRK-channel signaling by regulating RGS proteins. Trends in Pharmacological Sciences 29, 544-549.
27. Lucki I, Dalvi A, Mayorga AJ (2001). Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology 155, 315-322.
28. Maes M, Meltzer HY (1995). The serotonin hypothesis of major depression. In : Bloom FE, Kupfer DJ (Eds), Psychopharmacology : The Fourth Generation of Progress (pp. 933-944). New York: Raven Press.
29. Meller E, Chalfin M, Bohmaker K (1992). Serotonin 5HT1a receptor-mediated hypothermia in mice: absence of spare receptors and rapid induction of tolerance. Pharmacology Biochemistry and Behavior 43, 405-411.
30. Moy SS, Nadler JJ, Young NB, Nonneman RJ, et al. (2009). Social approach in genetically engineered mouse lines relevant to autism. Genes, Brain and Behavior 8, 129-142.
31. Nadler JJ, Moy SS, Dold G, Trang D, et al. (2004). Automated apparatus for qualification of social approach behaviors in mice. Genes, Brain and Behavior 3, 303-314.
32. Neubig RR, Siderovski DP (2002). Regulators of G-protein signaling as new central nervous system drug targets. Nature Reviews Drug Discovery 1, 187-197.
33. Nissen C, Holz J, Blechert J, Feige B, et al. (2010). Learning as a model for neuronal plasticity in major depression. Biological Psychiatry 68, 544-552.
34. Oliviera-dos-Santos AJ, Matsumoto G, Snow BE, Houston FP, et al. (2000). Regulation of t cell activation, anxiety and male aggression by RGS2. Proceedings of the National Academy of Sciences USA 97, 12272-12277.
35. Painsipp E, Wultsch T, Shahbazian A, Edelsbrunner M, et al. (2007). Experimental gastritis in mice enhances anxiety in a gender-related manner. Neuroscience 150, 522-536.
36. Pang TY, Du X, Zajac MS, Howard ML, Hannan AJ (2008). Altered serotonin receptor expression is associated with depression-related behavior in the r6/1 transgenic mouse model of Huntington's disease. Human Molecular Genetics 18, 753-766.
37. Ramboz S, Oosting R, Amara DA, Kung HF, et al. (1998). Serotonin receptor 1A knockout: an animal model of anxiety related disorder. Proceedings of the National Academy of Sciences USA 95, 14476-14481.
38. Robinet EA, Wurch T, Pauwels PJ (2001). Different regulation of RGS2 mRNA by haloperidol and clozapine. Neuroreport 12, 1731-1735.
39. Ross E-M, Wilkie TM (2000). GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. Annual Reviews of Biochemistry 69, 795-827.
40. Saavedra M, Contreras CM, Azamar-Arizmendi G, Hernandez-Lozano M (2006). Differential progesterone effects on defensive burying and forced swimming tests depending among gradual decrease or an abrupt suppression schedules. Pharmacology Biochemistry and Behavior 83, 130-135.
41. Santarelli L, Gobbi G, Debs PC, Sibille ET, et al. (2001). Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety related behaviors and increases serotonergic function. Proceedings of the National Academy of Sciences USA 98, 1912-1917.
42. Santarelli L, Saxe M, Gross C, Surget A, et al. (2003). Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301, 805-809.
43. Semplicini A, Lenzini L, Sartori M, Papparella I, et al. (2006). Reduced expression of regulator of G-protein signaling 2 (RGS2) in hypertensive patients increases calcium mobilization and ERK1/2 phosphorylation induced by angiotensin 2. Journal of Hypertension 24, 1115-1124.
44. Smoller JW, Paulus MP, Fagerness JA, Purcell S, et al. (2008). Influence of RGS2 on anxiety-related temperament, personality and brain function. Archives of General Psychiatry 65, 298-308.
45. Taymans JM, Kia HK, Claes R, Cruz C, et al. (2004). Dopamine receptor-mediated regulation of RGS2 and RGS4 mRNA differentially depends on ascending dopamine projections and time. European Journal of Neuroscience 19, 2249-2260.
46. Taymans JM, Leysen JE, Langlois X (2003). Striatal gene expression of RGS2 and RGS4 is specifically mediated by dopamine D1 and D2 receptors : clues for RGS2 and RGS4 functions. Journal of Neurochemistry 84, 1118-1127.
47. Traynor JR, Neubig RR (2005). Regulators of G protein signaling and drugs of abuse. Molecular Interventions 5, 30-41.
48. Tuomi JM, Chidiac P, Jones DL (2010). Evidence for enhanced M3 muscarinic receptor function and sensitivity to atrial arrhythmia in the RGS2-deficient mouse. American Journal of Physiology Heart and Circulatory Physiology 298, H554-H561.
49. Vollenweider I, Smith KS, Keist R, Rudolph U (2010). Antidepressant-like properties of a2-containing GABA(A) receptors. Behavioral Brain Research 217, 77-80.
50. Wang X, Zeng W, Soyombo AA, Tang W, et al. (2005). Spinophilin regulates Ca2+ signalling by binding the N-terminal domain of RGS2 and the third intracellular loop of G-protein-coupled receptors. Nature Cell Biology 7, 405-411.
51. Xie G, Palmer PP (2007). How regulators of G protein signaling achieve selective regulation. Journal of Molecular Biology 366, 349-365.
52. Yalcin B, Willis-Owen SA, Fullerton J, Meesaq A, et al. (2004). Genetic dissection of a behavioral quantitative trait locus shows that RGS2 modulates anxiety in mice. Nature Genetics 36, 1197-1202.